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Background: Arthritogenic alphaviruses such as Ross River virus (RRV) and chikungunya virus (CHIKV) have caused
widespread outbreaks of chronic polyarthritis. The inflammatory responses in alphavirus-induced arthritis and
osteoarthritis (OA) share many similar features, which suggests the possibility of exacerbated alphavirus-induced
bone pathology in individuals with pre-existing OA. Here, we investigated the susceptibility of osteoblasts (OBs)
from OA patients to RRV infection and dissected the immune mechanisms elicited from infection.
Methods: Primary hOBs obtained from trabecular bone of healthy donors and OA patients were infected with RRV.
Infectivity and viral replication were determined using flow cytometry and plaque assay, respectively. Real-time PCR
was performed to determine expression kinetics of type I interferon (IFN)-related immune mediators and osteotropic
factors.
Results: OA hOBs showed enhanced RRV infectivity and replication during infection, which was associated with
delayed induction of IFN-β and RIG-I expression. Enhanced susceptibility of OA hOBs to RRV was associated with a
more pronounced increase in RANKL/OPG ratio and expression of osteotropic factors (IL-6, IL-1β, TNF-α and CCL2) in
comparison to RRV-infected healthy hOBs.
Conclusions: Delayed activation of type I IFN-signalling pathway may have contributed to enhanced susceptibility to
RRV infection in hOBs from OA patients. RRV-induced increases in RANKL/OPG ratio and expression of osteotropic
factors that favour bone resorption, which may be exacerbated during osteoarthritis. This study provides the novel
insight that osteoarthritis may be a risk factor for exacerbated arthritogenic alphaviral infection.
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Ongoing global warming and increased rainfall variabil-
ity globally have provided extensive breeding grounds
for arthropod vectors. Infection rates of arthropod-borne
alphaviruses such as Ross River virus (RRV) and chikun-
gunya virus (CHIKV) are currently rising in different
geographic regions of the world [1]. Debilitating polyar-
thralgia/polyarthritis is the clinical hallmark of RRV and
CHIKV infection, which typically affects ankle joints,
knees and peripheral joints [2-4]. The onset of RRV dis-
ease (RRVD) and chikungunya fever (CHIKF) can be* Correspondence: s.mahalingam@griffith.edu.au
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unless otherwise stated.sudden and debilitating, with the level of disability com-
parable to other forms of arthritis such as osteoarthritis
(OA) or chronic rheumatoid arthritis (RA) [5].
Prolonged manifestations of chronic RRVD and CHIKF,
including persistent polyarthritis and/or polyarthralgias,
occur in approximately 40% of infected individuals [6].
Pro-inflammatory immune mediators, including interleu-
kin (IL)-6, IL-1, tumor necrosis factor-α (TNF-α) and
monocyte chemotactic protein-1 (MCP-1; or CCL2) have
been shown to contribute to the progression of alphaviral
disease [7-9]. Interestingly, these pro-inflammatory cyto-
kines are also known as osteotropic factors that modulate
the bone remodelling system.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ordinated action of bone-resorbing osteoclasts (OCs)
and bone-forming osteoblasts (OBs), which are together
termed the basic multicellular unit (BMU), to maintain
bone homeostasis. OBs are involved in bone formation
and mineralisation and orchestrate cell signalling path-
ways required for local control of OC differentiation
[10]. In most arthritic conditions, OCs have been identi-
fied as the principal cells responsible for bone erosions
[11]. Enhanced production of key OC differentiation
factors such as receptor activator of nuclear factor
(NF)-κβ ligand (RANKL), IL-6, IL-1 and TNF-α by OBs
can stimulate osteoclastogenesis [10,12]. To maintain
bone homeostasis, osteoclastogenesis is kept in check
by OB-secreted osteoprotegerin (OPG), which inhibits
OC differentiation by acting as a soluble decoy receptor
for RANKL. Hence, an increase in RANKL/OPG ratio is
associated with increased OC activity, which may result
in osteolytic pathologies [13-15].
Clinical evidence of bony erosions has been reported
in the joints of CHIKV-infected patients [16], providing
evidence that alphavirus-induced disease can result in
erosive arthritis. Recently, we reported pathologic bone
loss during acute RRV infection in an acute RRVD
mouse model, which is consistent with the increased
tartrate-resistant acid phosphatase 5b (TRAP5b) level
and RANKL/OPG ratio in serum of RRV patients. RRV
infection of primary human osteoblasts (hOBs) also
leads to an increased RANKL/OPG ratio and robust
production of pro-inflammatory cytokines IL-6 and
CCL2 [17].
OA, also known as degenerative joint arthritis, is the
most common form of arthritis. It is characterized by
degradation of cartilage and inflammation of the syno-
vium and affects millions of people worldwide, with an
estimate of over 1.4 million people affected in Australia
alone [18]. Pro-inflammatory cytokines such as IL-6, IL-
1, TNF-α and CCL2 are involved in OA severity: this
cytokine profile has a striking resemblance to inflamma-
tory responses elicited in alphavirus-induced arthritis
[19]. The shared cytokine profile between alphavirus-
induced arthritis and OA highlights a potential for
exacerbation of alphavirus-induced bone loss in individ-
uals with pre-existing OA [3,20,21].
In this study, we investigated the potential of underlying
OA to influence alphavirus infection. RRV infection of
OA hOBs led to enhanced viral infectivity and replica-
tion, accompanied by delayed type I IFN responses.
RRV-induced pro-inflammatory immune responses were
increased in OA hOBs. The imbalance in the RANKL/
OPG axis that results from RRV infection was further
perturbed in hOBs from OA patients, suggesting OA
as a predisposing risk factor for alphavirus-induced
bone pathology.Results
Enhanced RRV infectivity in primary hOBs of OA patients,
modulated through delayed type IFN signalling pathway
To investigate if underlying OA has any effect on viral rep-
lication during RRV infection, primary hOBs cultured from
trabecular bones of healthy donors and OA patients were
used. The cultured primary hOBs were phenotypically char-
acterized using osteocalcin, an OB marker, prior to RRV in-
fection (Figure 1A). To determine the infectivity of these
primary hOB cultures, they were infected with RRV-EGFP
at a series of multiplicity of infection (MOI) from 1 to 10.
Infectivity of both healthy and OA hOBs was demonstrated
in a dose-dependent manner (Figure 1B). The kinetics of
RRV replication in the primary hOBs was further deter-
mined through a 96 h time-course infection, with cells and
supernatant harvested at 24, 48 and 96 hours post-infection
(hpi) for FACS analysis and plaque assays. Peak RRV repli-
cation was observed at 24 hpi for both healthy and OA
hOBs, with a subsequent decline over the next 72 h. Inter-
estingly, FACS analysis of the harvested cells revealed sig-
nificantly enhanced RRV infectivity in OA hOBs at 24, 48
and 96 hpi (Figure 1C). Consistent with the enhanced
infectivity in OA hOBs, higher levels of virus were also re-
covered from the supernatant of infected OA hOBs at 24
and 48 hpi, compared to healthy hOBs (Figure 1D).
The type I IFN signalling pathway serves as the first line
of host defence against pathogen invasion. We sought to
determine the involvement of type I IFN in the contribu-
tion of enhanced RRV infectivity and replication in OA
hOBs. Infected primary hOBs were harvested at 24, 48 and
96 hpi for determination of IFN-β and RIG-I mRNA ex-
pression (Figure 2). At the peak viral replication of 24 hpi,
RRV-infected OA hOBs had significantly lower transcrip-
tional induction of both IFN-β and RIG-I compared to
RRV-infected healthy hOBs. The induction of IFN-β and
RIG-I in RRV-infected OA hOBs gradually overtook that of
RRV-infected healthy hOBs at 48 and 96 hpi, respectively.
Together, these data suggest that enhanced susceptibility
and viral replication in OA hOBs may be modulated
through delayed induction of type I IFN.
Underlying OA further perturbs bone homeostasis after
RRV infection
Alphavirus-induced arthritis and OA are inflammatory ar-
thritides that have been associated with bone disorders
[17,22]. Recently, we demonstrated that RRV infection can
elicit bone loss through perturbed OB function. Therefore,
we investigated the effect of RRV infection on bone regula-
tory function of OA hOBs by measuring RANKL and
OPG, which are the fundamental elements of bone homeo-
stasis. Briefly, primary hOB cultures were infected at MOI
1 and harvested at 24, 48 and 96 hpi for determination of
RANKL and OPG transcript expression. RANKL expres-
sion in OA hOBs was significantly higher at all time points
Figure 1 (See legend on next page.)
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Figure 1 Enhanced RRV replication in primary hOBs of OA patients. (A) Phenotypic characterization of primary hOBs. Primary hOBs were fixed and
stained for osteocalcin (green) and nuclei (blue), and visualized by confocal microscopy. Magnification, ×20. Images are representative of 2 independent
experiments. Primary hOBs were infected with RRV-EGFP at MOI 1 and cells and supernatant were harvested at different time points. (B) Dose-dependent
infection of hOBs. Cell harvested at 24 hpi were fixed, stained for 7-AAD, and subjected to FACS analysis. FACS scatter plots are representative of the data
obtained for 3 independent experiments. (C) Quantification of percentage EGFP+ cells after infection. (D) Supernatant was harvested and RRV titre was
determined by plaque assay on Vero cells. Data (n =4) are presented as mean± SEM. *P <0.05, two-way ANOVA, Bonferroni post-test.
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crease in RANKL expression of ~20-fold between 24 to 96
hpi was observed in RRV-infected OA hOBs, compared
to ~5-fold increase for RRV-infected healthy hOBs. No
significant difference in RANKL expression was observed
between mock-infected healthy and OA hOBs (Figure 3A).
Higher levels of OPG expression were detected in mock-
infected OA hOBs compared to mock- or RRV-infected
healthy hOBs. After RRV infection, OA hOBs demon-
strated higher expression of OPG compared to healthy in-
fected hOBs at all tested time points. No significant
changes in OPG expression were observed between mock-
or RRV-infected healthy hOBs at all tested time points.
However, at 48 and 96 hpi, OPG levels were significantlyFigure 2 Delayed IFN-signalling pathway in primary hOBs of OA patien
MOI 1 and cells were harvested at different time points for RNA extraction. Tr
qRT-PCR. Data are normalized to HPRT and shown as fold expression relative
SEM. *P <0.05, one-way ANOVA, Tukey’s post-test.lower in the RRV-infected OA hOBs compared to mock-
infected OA hOBs (Figure 3B). Thus, RRV infection
resulted in a markedly elevated RANKL/OPG ratio in both
healthy and OA hOBs compared to mock-infected groups.
Interestingly, OA hOBs exhibited a significantly higher
RANKL/OPG ratio than healthy hOBs after RRV infection
at 48 and 96 hpi (Figure 3C), suggesting that underlying
OA may exacerbate RRV-induced bone pathology by fur-
ther increasing the RANKL/OPG ratio.
Increased expression of osteotropic factors in primary
hOBs of OA patients after RRV infection
Pro-inflammatory mediators such as IL-6, IL-1β, TNF-α
and CCL2 contribute to alphaviral disease pathogenesis.ts during RRV infection. Primary hOBs were infected with EGFP-RRV at
anscriptional profiles of (A) IFN-β and (B) RIG-I were determined using
to healthy mock-infected group. Data (n =4) are presented as mean ±
Figure 3 Underlying OA condition further perturbs RANKL/OPG ratio after RRV infection in primary hOBs. Primary hOBs were infected
with EGFP-RRV at MOI 1 and cells were harvested at different time points for RNA extraction. Transcriptional profiles of (A) RANKL and (B) OPG
were determined using qRT-PCR. (C) RANKL/OPG ratio is shown. Data are normalized to HPRT and shown as fold expression relative to healthy
mock-infected group. Data (n =4) are presented as mean ± SEM. *P <0.05, one-way ANOVA, Tukey’s post-test.
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osteotropic factors, with a pivotal role in modulating
bone remodelling [23,24]. Transcriptional analysis ofthese osteotropic factors was performed to assess their
expression kinetics. IL-6 expression was up-regulated at
all tested time points after RRV infection in both
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of OA hOBs elicited consistently lower levels of IL-6
transcription compared to healthy hOBs, but its expres-
sion was increased at 96 hpi (Figure 4A). Early induc-
tion of IL-1β expression was observed in both healthy
and OA hOBs after RRV infection at 24 hpi, which peaked
at 48 hpi, with ~30-fold increase for RRV-infected healthy
hOBs and ~90-fold increase for RRV-infected OA hOBs.
At 96 hpi, the RRV-induced expression of IL-1β in healthy
hOBs declined, while transcription continued to increase
dramatically to ~600-fold change in RRV-infected OA
hOBs (Figure 4B). Elevated expression of TNF-α was de-
tected at 24 hpi in RRV-infected healthy and OA hOBs,
but to a lesser extent for the OA group. The induction of
TNF-α declined rapidly at 48 hpi and reverted to basal
level by 96 hpi (Figure 4C). CCL2 expression was highly
up-regulated in healthy hOBs after RRV infection at 24
hpi and decreased gradually over the next 72 h. In con-
trast, RRV-induced CCL2 expression in OA hOBs only
commenced at 96 hpi (Figure 4D). Collectively, the ele-
vated expression of these pro-inflammatory/osteotropic
factors at later stages of infection may stimulate RANKL-
mediated osteoclastogenesis.
Discussion
Alphavirus-infected patients suffering from pre-existing
joint disorders such as OA have been reported to be at
possible increased risk of severe joint arthralgia and de-
layed remission [3,16,20,25,26]. However, the mechanism
behind prolonged and exacerbated disease in patients
with underlying arthritis has not been elucidated. Our
previous findings highlighted that alphaviruses possess
tropism for murine bones and that OB-lineage cells have
potential roles in the pathogenesis of alphaviral arthritis
[17,27,28]. This study was undertaken to investigate the
susceptibility and response of primary hOB from OA pa-
tients to arthritogenic RRV infection and to analyse if in-
fection can exacerbate hOB osteoclastogenic potential.
Primary hOBs from OA patients were significantly
more susceptible to RRV infection and the virus repli-
cated at higher levels compared to hOBs from healthy
donors. Alphaviruses are susceptible to type I IFNs,
which was elicited in response to RNA viruses by the
cytoplasmic RNA sensor RIG-I [29-32]. A possible ex-
planation for the enhanced infection of OA hOBs was
the lower expression of RIG-I and IFN-β compared to
healthy cells at peak infection (24 hpi), suggesting a de-
layed IFN-signalling pathway in OA hOBs.
Bone cells such as OB play a pivotal role in bone re-
modelling, with primary role in bone formation and
regulation of OC bone resorption through the OPG/
RANKL/RANK system [33,34]. Cells of OB lineage
express both RANKL and OPG, which are key osteotro-
pic factors in regulating bone remodelling; a higherRANKL/OPG ratio favours osteoclastogenesis [13-15].
At basal levels, we found a lower RANKL/OPG ratio in
OA hOBs than healthy hOBs. This is in agreement with
previous studies showing that OA patients have a
lower RANKL/OPG ratio, suggesting reduced osteoclastic
activity [35,36]. In contrast to the lower RANKL/OPG
ratio in OA hOBs, the ratio in these cells was signifi-
cantly increased after 96 h RRV infection compared to
healthy infected cells, highlighting the potential of OA
predisposed to exacerbated alphavirus-induced bone
pathology.
Pro-inflammatory/osteotropic factors are crucial in
both bone remodelling and in the pathogenesis of alpha-
virus infection. For example, IL-6 is highly expressed in
affected joints during alphavirus disease [37] and is pro-
posed to be an index of CHIKV disease severity [8,38].
Recently, we showed that IL-6, IL-1β, TNF-α and CCL2
are highly expressed in RRV-infected hOBs of healthy
donors and that these infected cells are crucial in medi-
ating RRV-induced bone loss through the up-regulation
of RANKL/OPG ratio [17]. Similarly, we observed up-
regulation of IL-6, IL-1β and TNF-α in OA hOBs at
peak infection (24 hpi) in our study. Although RRV-
induced IL-6, TNF-α and CCL2 were lower in the OA
hOBs compared to infected controls during early infec-
tion, the expression of these osteotropic factors in OA
hOBs, with the exception of TNF-α, was significantly el-
evated at 96 hpi. Hence, the increased expression of IL-
6, IL-1β and CCL2 at later stages of infection may act to
promote osteoclastogenesis. This is supported by the
high RANKL/OPG ratio, a well-established index for os-
teoclastogenesis, in OA hOB after 96 hpi compared to
infected controls.
Our in vitro findings are the first to demonstrate in-
creased susceptibility of primary OA hOBs to RRV infec-
tion, which may contribute to disease exacerbation in
patients with underlying inflammatory arthritis.
Conclusions
These exciting results clearly indicate that the response
of ‘arthritic’ osteoblasts to RRV infection differs from
normal osteoblasts; they are more susceptible to infec-
tion possibly through delayed type I IFNs response and
produce higher levels of IL-6, IL-1β, CCL2 and TNF-α.
At later stages of infection, RRV-infected OA hOBs
showed significantly increased IL-6, IL-1β and CCL2 ex-
pression compared to healthy infected controls. The in-
crease in these pro-inflammatory/osteotropic factors by
OA hOBs may act to recruit monocytic OC precursor
cells to sites of infection and to enhance the expression
of RANKL in RRV-infected hOBs. These delayed
pro-inflammatory responses resulted in an increased
RANKL/OPG ratio, which can lead to increased osteo-
clastogenesis. Our novel findings highlight a possible
Figure 4 (See legend on next page.)
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Figure 4 Enhanced expression of osteotropic factors in primary hOBs of OA patients after RRV infection. Primary hOBs were infected
with EGFP-RRV at MOI 1 and cells were harvested at different time points for RNA extraction. Transcriptional profiles of osteotropic factors (A) IL-6,
(B) IL-1β, (C) TNF-α and (D) CCL2 were determined using qRT-PCR. Data are normalized to HPRT and shown as fold expression relative to healthy
mock-infected group. Data (n =4) are presented as mean ± SEM. *P <0.05, one-way ANOVA, Tukey’s post-test.
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joint arthralgia and prolonged disease severity after RRV
infection in patients with underlying OA.
Methods
Viruses
Stocks of RRV strain T48 (RRV-T48) were generated from
the full-length T48 cDNA clone [39]. Stocks of RRV that
expressed enhanced green fluorescent protein (RRV-EGFP)
were generated by inserting a second RRV 26S promoter
sequence at the 3′ end of the viral genome, followed by the
coding sequence for EGFP (kindly provided by Dr Mark
Heise, University of North Carolina). All titrations were
performed by plaque assay on Vero cells as described previ-
ously [40].
Primary cell cultures
Primary human OB (hOB) cultures were obtained from tra-
becular bone specimens of 7 healthy individuals (4 males, 3
females), aged 50–60 years. Healthy hOBs were obtained
from individuals undergoing orthopaedic operations for
causes unrelated to arthritis and osteoporosis (such as liga-
ment reconstruction or trauma cases). OA trabecular bone
specimens were obtained from femur neck of 5 patients (3
males, 2 females) undergoing primary or revision surgery.
The patients ranged in age from 50–60 years and were di-
agnosed with OA according to the World Health Organisa-
tion (WHO) criteria, mainly based on clinical presentation,
radiographic findings. All human specimens were collected
with the permission of the Human Research Ethics
Committee of Australian National University (human ethics
approval-ETH-9-07-865) and Australian Capital Territory
(ACT) Health, together with informed patient consent. The
exclusion criteria for recruiting hOB donors was (i) taking
immune suppressant/stimulating drugs, cytokine, or IFN
therapy in the 3 months before surgery; (ii) treatment with
anabolic agents; and (iii) low quality of the bone fragment,
socio-economic or ethic characteristics and age not match-
ing with the healthy group, in the opinion of the investiga-
tors, could compromise the study. Briefly, the bone
fragments were washed with PBS and cultured in α-MEM
(Sigma-Aldrich) supplemented with 10% HI-FCS, 1% anti-
biotic solution, 100 μM ascorbic acid, 20 mM Hepes, and
2 mM L-glutamine at 37°C with 5% CO2. After 2 weeks,
outgrowing cells surrounding bone fragments were cul-
tured and designated as “passage 1.” The hOBs cultured in
our laboratory were able to proliferate in vitro for up to five
passages but were used at passage 2 in all experiments.Phenotypic characterisation of primary human osteoblasts
(hOBs)
To characterise cultured hOB, osteocalcin expression
was determined by staining hOB with primary mouse anti-
human osteocalcin monoclonal antibodies (R&D Systems,
Minneapolis, USA) and Alexa-Fluor 488 (AF488) goat anti-
mouse IgG (Invitrogen, Melbourne, Victoria, Australia),
followed by DAPI staining and visualisation using an
FV1000 confocal microscope (Olympus, Australia).
In vitro RRV infection
Primary hOBs were seeded in 24-well plates at a density
of 1 × 105 cells per well overnight. Cells were then in-
fected with RRV-EGFP at a multiplicity of infection (MOI)
of 1. After 1 h, cells were washed twice and cultured in
fresh α-MEM with 10% FCS at 37°C with 5% CO2. At ap-
propriate time points, culture medium was collected for
plaque assay and cells were harvested for RNA extraction.
Flow Cytometry (FACS)
Cells were trypsinsed and washed twice in wash buffer
(PBS-2% FCS). Cells were then stained with 7-AAD (7-
aminoactinomycin) (eBioscience, San Diego, CA) at
room temperature for 10 min. Following 7-AAD stain-
ing, EGFP expression in RRV-infected cells was analysed
using a CyAn ADP flow cytometer and Kaluza software
(Beckman Coulter).
Plaque assays
Vero cells were seeded into 24-well plates at a density of 1 ×
105 cells per well and cultured to confluence. Serially diluted
samples (10−1 to 10−6) were added to cell monolayers and
incubated for 1 h at 37°C in a 5% CO2 incubator. Cells were
then overlaid with OPTI-MEM (Invitrogen, Melbourne,
Victoria, Australia) containing 3% FCS and 1% agarose
(Sigma Aldrich, Sydney, Australia) and incubated for 48 h in
a 5% CO2 incubator. The cells were fixed with 1% formalin
and plaques were visualised by staining with 0.1% crystal
violet. Virus titres were expressed as plaque forming units
per millilitre (PFU/mL) or PFU per gram of tissue.
Real-time PCR (qRT-PCR)
RNA was prepared from cell pellets using TRIzol
(Invitrogen, Melbourne, Victoria, Australia) according to
the manufacturer’s instructions. Eluted RNA was stored
at −80°C. Total RNA was measured by NanoDrop 1000
spectrophotometer (Thermo Scientific). Extracted total
RNA (20 ng/μL) was reverse-transcribed using an oligo(dT)
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Australia), according to the manufacturer’s instructions.
SYBR® Green Real-time PCR was performed using 50 ng of
template cDNA on a CFX96 Touch™ Real-Time PCR Sys-
tem in 96-well plates, using QuantiTect Primer Assay kits
(Qiagen, Hilden, Germany) with the following conditions:
(i) PCR initial activation step: 95°C for 15 min, 1 cycle and
(ii) 3-step cycling: 94°C for 15 s, follow by 55°C for 30 s and
72°C for 30 s, 40 cycles. Amplification specificity was evalu-
ated by a melting curve analysis of PCR products. The fold
change in messenger RNA (mRNA) expression relative to
mock-infected samples for each gene was calculated with
the ΔΔCt method. Briefly, ΔΔCt =ΔCt (RRV-infected) –
ΔCt (Mock-infected) with ΔCt =Ct (gene of interest) – Ct
(housekeeping gene - HPRT). The fold change for each
gene is calculated as 2-ΔΔCt.
Statistical analysis
Viral titers and flow cytometry data were statistically
evaluated using two-way analysis of variance (ANOVA)
with Bonferroni posttest. Real-time PCR data were ana-
lyzed using one-way ANOVA with Tukey’s posttest. Dif-
ferences between groups with P <0.05 were considered
significant. All data were assessed for normality using
the D’Agostino-Pearson normality test before analysis
with these parametric tests. All statistical analyses were
performed with GraphPad Prism software, version 5.02.
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